# New ovarian cancer clinical trials, last 30 days: 22 (2026)

Updated November 19, 2026.

22 new trials for ovarian cancer were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New ovarian cancer clinical trials, last 30 days: 22 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/new/ovarian-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942090 | Role of 68Ga-FAPI PET/CT in Patients in Whom 18F-FDG PET/CT Has Been Found to be Questionable or Inconclusive Due to Oncological Pathology | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Not applicable | Enrolling by invitation | Lung Cancer Diagnosis, Head and Neck Cancer (H&N), Breast Cancer, Ovarian Cancer | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942090) |
| November 17, 2026 | NCT07940881 | A Multicenter, Open-label, Phase 1/1b, Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SI-B037 in Solid Tumors | SystImmune Inc. | Phase 1 | Recruiting | Locally Advanced /Metastatic Solid Tumors, Locally Advanced / Metastatic Solid Tumors, First in Human, Metastatic Solid... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940881) |
| November 16, 2026 | NCT07940062 | Co-Existent Endometrial and Ovarian Carcinoma: Molecular Stratification for Pathologic Reporting and Clinical Management | British Columbia Cancer Agency | Phase 2 | Not yet recruiting | Co-existent Endometrial and Ovarian Carcinoma, Ovarian Carcinoma, Endometrial Carcinoma (EC) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940062) |
| November 16, 2026 | NCT07940049 | CovaRisk: Validating a Digital Tool for Ovarian Cancer Risk Assessment and Referral | Benha University | Observational | Not yet recruiting | Cancer Ovaries, Ovarian Mass, Borderline Ovarian Cancer | 320 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940049) |
| November 12, 2026 | NCT07934121 | MIRV in Combination With Suvemcitug for Partially Platinum-Sensitive Ovarian Cancer | Tongji Hospital | Phase 2 | Not yet recruiting | Platinum-Sensitive Recurrent Ovarian Cancer | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934121) |
| November 12, 2026 | NCT07933419 | Phase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid Tumors | Qilu Pharmaceutical Co., Ltd. | Phase 1/2 | Not yet recruiting | Clear Cell Renal Cell Carcinoma, Ovarian Cancer, Other Advanced Solid Tumors | 558 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933419) |
| November 12, 2026 | NCT07932106 | Identifying Mediators of Exercise-induced Tumor Microenvironment Remodeling to Enhance Primary Chemotherapy Response (IMPROVE-Ovarian) | University of Pittsburgh | Not applicable | Not yet recruiting | High Grade Serous Ovarian, Ovarian Adenocarcinoma, Ovarian Cancer, Serous Adenocarcinoma of Ovary, Ovarian Cancer (OvCa) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932106) |
| November 12, 2026 | NCT07931989 | AI-Assisted Remote Monitoring for Patients With or at Risk of Malignant Bowel Obstruction | Hospital Universitario 12 de Octubre | Not applicable | Not yet recruiting | Malignant Bowel Obstruction, Intestinal Obstruction | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931989) |
| November 10, 2026 | NCT07928258 | A Study of LY4336619 in Adult Participants With Advanced Solid Tumors | Eli Lilly and Company | Phase 1 | Not yet recruiting | Endometrial Neoplasms, Ovarian Neoplasms, Neoplasms, Germ Cell and Embryonal, Carcinoma, Non-Small-Cell Lung, Stomach... | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928258) |
| November 9, 2026 | NCT07926048 | A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | Qilu Pharmaceutical Co., Ltd. | Phase 3 | Not yet recruiting | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 420 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926048) |
| November 6, 2026 | NCT07923214 | A Phase I Dose Escalation Study of CG-7321 Monotherapy or Combination Therapy in Advanced Solid Tumors | Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | Phase 1 | Recruiting | Advanced Solid Tumors, Breast Cancer, Ovarian Cancer, Gastric Cancer, Other Solid Tumors | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923214) |
| November 4, 2026 | NCT07915336 | Peer Ambassador in Gyn Onc Trials | Abramson Cancer Center at Penn Medicine | Not applicable | Enrolling by invitation | Ovarian Cancer | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915336) |
| November 2, 2026 | NCT07909031 | CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors | Crescent Biopharma, Inc. | Phase 1/2 | Recruiting | Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)... | 219 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909031) |
| October 29, 2026 | NCT07905677 | Phase 1 Study of VT-101 in Advanced Ovarian Cancer | Sponsor not shown (see the record) | Phase 1 | Recruiting | Epithelial Ovarian Cancer, Ovarian Cancer | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905677) |
| October 28, 2026 | NCT07902375 | Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers | Universiteit Antwerpen | Not applicable | Recruiting | Gynaecological Cancers, Ovarian Cancer, Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Postmenopausal Bleeding... | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902375) |
| October 27, 2026 | NCT07896421 | Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and... | AbbVie | Observational | Recruiting | Platinum-Resistant FRα-Positive Ovarian Cancer, Platinum-Resistant FRα-Positive Fallopian Tube Cancer... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896421) |
| October 26, 2026 | NCT07895212 | Feasibility of the "One-Finger Technique" for Identifying the Upper Left Ureter During Para-Aortic Lymphadenectomy | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Not applicable | Recruiting | Ovary Cancer, Cervical Cancer, Endometrial Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895212) |
| October 26, 2026 | NCT07894874 | A Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors. | InventisBio Yiqi Beijing Limited | Phase 1 | Not yet recruiting | Solid Tumor (Phase I), Ovarian Cancer, NSCLC (Advanced Non-small Cell Lung Cancer), TNBC - Triple-Negative Breast Cancer | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07894874) |
| October 22, 2026 | NCT07889843 | Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian Cancer | Hellenic Cooperative Oncology Group | Observational | Recruiting | High Grade Serous Ovarian Cancer, Folate Receptor Alpha Positive | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889843) |
| October 20, 2026 | NCT07883798 | Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Observational | Recruiting | Cervical Cancer, Gynecologic Cancer, Endometrial Cancer, Uterine Cancer, Uterine Sarcoma, Ovarian Cancer, Fallopian... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883798) |
| October 20, 2026 | NCT07883551 | AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery | Catharina Ziekenhuis Eindhoven | Observational | Not yet recruiting | Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor | 1,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883551) |
| October 20, 2026 | NCT07882485 | Effects of Web-Based Ovarian Cancer Awareness Education on Women's Health Beliefs and Risk-Reducing Behaviors | Ege University | Not applicable | Not yet recruiting | Ovarian Cancer | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882485) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Not applicable | 7 |
| Observational | 5 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| [Qilu Pharmaceutical Co., Ltd.](https://specstream.ai/data/clinical-trials/company/qilu-pharmaceutical-co-ltd) | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 1 |
| SystImmune Inc. | 1 |
| British Columbia Cancer Agency | 1 |
| Benha University | 1 |
| Tongji Hospital | 1 |
| University of Pittsburgh | 1 |
| Hospital Universitario 12 de Octubre | 1 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 1 |
| Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Crescent Biopharma, Inc. | 1 |
| Universiteit Antwerpen | 1 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| InventisBio Yiqi Beijing Limited | 1 |
| Hellenic Cooperative Oncology Group | 1 |
| Affidea Nu-med Center of Oncological DIagnostics and Therapy | 1 |
| Catharina Ziekenhuis Eindhoven | 1 |
| Ege University | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beach resorts in the United States](https://specstream.ai/data/businesses/beach-resorts/united-states)
- [Flour mills in the United States](https://specstream.ai/data/businesses/flour-mills/united-states)
- [Optical wholesalers in the United States](https://specstream.ai/data/businesses/optical-wholesalers/united-states)
- [Translation and interpreting companies in the United States](https://specstream.ai/data/businesses/translation-and-interpreting-companies/united-states)
- [Carpet cleaning companies in the United States](https://specstream.ai/data/businesses/carpet-cleaning-companies/united-states)
- [High schools in the United States](https://specstream.ai/data/businesses/high-schools/united-states)
